BioHealth News Archive
Immunomic’s Academic Collaborator Dr. John Sampson Recognized as “World Expert” in Glioblastoma as Part of Glioblastoma Awareness Day | Business Wire
ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today that its’…
Read More
BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD · BioBuzz
MAINZ, Germany & SANTA MONICA, Calif.–(BUSINESS WIRE)–BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Kite, a Gilead Company (Nasdaq: GILD, “Kite”) today announced the two companies…
Read MoreAlexandria Plans 200K SF Lab Building To Kick Off Huge Rockville Project
Montgomery County is set to consider plans for the first phase of a five-building life sciences project in Rockville. An affiliate of life sciences…
Read MoreScience Magazine: ARPA-H: Accelerating biomedical breakthroughs | The White House
The biomedical research ecosystem has delivered advances that not long ago would have been inconceivable, exemplified by highly effective COVID-19 vaccines developed by global…
Read More
Game Changers | VT Corporate Research Center
Come join the Virginia Tech Corporate Research Center for Game Changer Week! Game Changer Week, set for August 23-27, 2021 will bring together industry…
Read More
Ascentage Pharma Establishes Cooperative R&D Agreement (CRADA) with the National Cancer Institute for Clinical Development of Ascentage Pharma’s Drug Compound pelcitoclax | BioSpace
SUZHOU, China, and ROCKVILLE, Md., July 19, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers,…
Read More
Join Our Celebration | American Gene Technologies
The Data Safety and Monitoring Board has met and evaluated the safety data from the first participant treated with AGT103-T, our HIV-cure drug candidate.…
Read More
Maryland-based Novavax’s effort to vaccinate the world, from zero to not quite warp speed: ‘This takes time and expertise’ – Baltimore Sun
On a sweltering June morning, Novavax CEO and COVID vaccine maker Stanley Erck stood on a stage unmasked and did something that would have…
Read More
Citybiz Interview with Ronald Piervincenzi, CEO of U.S. Pharmacopeia | citybiz
Ronald T. Piervincenzi, Ph.D., has served as Chief Executive Officer of the U.S. Pharmacopeia (USP) since February 2014. USP is an independent, nonprofit, scientific…
Read More
Exclusive: White House taps Maryland professor for tech role
President Biden will nominate Laurie E. Locascio to lead the federal agency in charge of promoting innovation and technology, the National Institute of Standards…
Read More
GSK to build $549m biotech hub in Stevenage, UK
GlaxoSmithKline (GSK) has plans to open an approximately $549m (£400m) biotechnology campus in Stevenage, UK, which would possibly create up to 5,000 skilled jobs…
Read MoreWith $1.27B raised, DC stays on record-setting pace for venture capital funding in 2021 – Technical.ly DC
Venture capital totals for D.C. area companies got off to a strong start in 2021, and they’re continuing to rise with a new record…
Read More
A new portfolio model for Pharmaceutical & Medical Products in biotech | McKinsey
Until recently, biotech companies tended to be founded with a focus on a single technology or biological pathway. An early exemplar of this was…
Read More
Johns Hopkins AI spinout launches clinical diagnostics tool – Insider Intelligence Trends, Forecasts & Statistics
The news: Johns Hopkins spinoff Bayesian Health has $15 million in VC backing to offer an AI-based clinical decision support platform designed to make…
Read More
Beckham Gumbin Ventures Announces Ballenger Bio: A Life Sciences Conversion and Innovation Center Coming to Frederick, Maryland | Benzinga
FREDERICK, Md., July 15, 2021 /PRNewswire-PRWeb/ -- Beckham Gumbin Ventures (BGV), a commercial real estate investor and developer, is beginning construction on brand new…
Read More